ArticleAmerican journal of cancer research2018

An anti-ASCT2 monoclonal antibody suppresses gastric cancer growth by inducing oxidative stress and antibody dependent cellular toxicity in preclinical models.

Aya Osanai-Sasakawa et al.PubMed ↗Full text ↗

No numbers read from the abstract.